Overview
Bremelanotide is included in DrugStatusIndex as part of a structured FDA-status reference covering medications, compounds, peptides, and drug-name search terms.
Bremelanotide is FDA approved by prescription for acquired, generalized hypoactive sexual desire disorder in premenopausal women under its labeling.
Bremelanotide is included in DrugStatusIndex as part of a structured FDA-status reference covering medications, compounds, peptides, and drug-name search terms.
Current working status: FDA Approved. FDA-approved prescription medication with a specific labeled indication.
Available through licensed pharmacies when prescribed; injectable product.
FDA-approved injectable product; compounding is generally not needed when approved product is available.
Use DrugStatusIndex to review FDA approval status, prescription classification, and regulatory context.